Neurology Clinical Trials Market Size, Share & Trends Analysis Report By Phase (Phase I, Phase II, Phase III, Phase IV), By Study Design (Interventional, Observational, Expanded Access), By Indication (Epilepsy, Parkinson's Disease (PD), Huntington's Disease, Stroke, Traumatic Brain Injury (TBI), Amyotrophic Lateral Sclerosis (ALS), Muscle regeneration, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: June 03, 2026 | Author: Jay Mehta | Format: | Report Code: SR2856DR | Pages: 110

Table Of Content

  1. Executive Summary

  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Neurology Clinical Trials Market Size Analysis
    1. Introduction
    2. Neurology Clinical Trials Market Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
      1. Phase I
      2. Phase II
      3. Phase III
      4. Phase IV
    3. Neurology Clinical Trials Market Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
      1. Interventional
      2. Observational
      3. Expanded Access
    4. Neurology Clinical Trials Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
      1. Epilepsy
      2. Parkinson's Disease (PD)
      3. Huntington's Disease
      4. Stroke
      5. Traumatic Brain Injury (TBI)
      6. Amyotrophic Lateral Sclerosis (ALS)
      7. Muscle regeneration
      8. Others
  7. North America Neurology Clinical Trials Market Size Analysis
    1. Introduction
    2. Neurology Clinical Trials Market Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
      1. Phase I
      2. Phase II
      3. Phase III
      4. Phase IV
    3. Neurology Clinical Trials Market Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
      1. Interventional
      2. Observational
      3. Expanded Access
    4. Neurology Clinical Trials Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
      1. Epilepsy
      2. Parkinson's Disease (PD)
      3. Huntington's Disease
      4. Stroke
      5. Traumatic Brain Injury (TBI)
      6. Amyotrophic Lateral Sclerosis (ALS)
      7. Muscle regeneration
      8. Others
    5. U.S. Neurology Clinical Trials Market Size Analysis
      1. Introduction
      2. Neurology Clinical Trials Market Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      3. Neurology Clinical Trials Market Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
        1. Interventional
        2. Observational
        3. Expanded Access
      4. Neurology Clinical Trials Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Epilepsy
        2. Parkinson's Disease (PD)
        3. Huntington's Disease
        4. Stroke
        5. Traumatic Brain Injury (TBI)
        6. Amyotrophic Lateral Sclerosis (ALS)
        7. Muscle regeneration
        8. Others
    6. Canada Neurology Clinical Trials Market Size Analysis
      1. Introduction
      2. Neurology Clinical Trials Market Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      3. Neurology Clinical Trials Market Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
        1. Interventional
        2. Observational
        3. Expanded Access
      4. Neurology Clinical Trials Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Epilepsy
        2. Parkinson's Disease (PD)
        3. Huntington's Disease
        4. Stroke
        5. Traumatic Brain Injury (TBI)
        6. Amyotrophic Lateral Sclerosis (ALS)
        7. Muscle regeneration
        8. Others
  8. Europe Neurology Clinical Trials Market Size Analysis
    1. Introduction
    2. Neurology Clinical Trials Market Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
      1. Phase I
      2. Phase II
      3. Phase III
      4. Phase IV
    3. Neurology Clinical Trials Market Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
      1. Interventional
      2. Observational
      3. Expanded Access
    4. Neurology Clinical Trials Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
      1. Epilepsy
      2. Parkinson's Disease (PD)
      3. Huntington's Disease
      4. Stroke
      5. Traumatic Brain Injury (TBI)
      6. Amyotrophic Lateral Sclerosis (ALS)
      7. Muscle regeneration
      8. Others
    5. U.K. Neurology Clinical Trials Market Size Analysis
      1. Introduction
      2. Neurology Clinical Trials Market Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      3. Neurology Clinical Trials Market Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
        1. Interventional
        2. Observational
        3. Expanded Access
      4. Neurology Clinical Trials Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Epilepsy
        2. Parkinson's Disease (PD)
        3. Huntington's Disease
        4. Stroke
        5. Traumatic Brain Injury (TBI)
        6. Amyotrophic Lateral Sclerosis (ALS)
        7. Muscle regeneration
        8. Others
    6. Germany Neurology Clinical Trials Market Size Analysis
      1. Introduction
      2. Neurology Clinical Trials Market Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      3. Neurology Clinical Trials Market Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
        1. Interventional
        2. Observational
        3. Expanded Access
      4. Neurology Clinical Trials Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Epilepsy
        2. Parkinson's Disease (PD)
        3. Huntington's Disease
        4. Stroke
        5. Traumatic Brain Injury (TBI)
        6. Amyotrophic Lateral Sclerosis (ALS)
        7. Muscle regeneration
        8. Others
    7. France Neurology Clinical Trials Market Size Analysis
      1. Introduction
      2. Neurology Clinical Trials Market Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      3. Neurology Clinical Trials Market Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
        1. Interventional
        2. Observational
        3. Expanded Access
      4. Neurology Clinical Trials Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Epilepsy
        2. Parkinson's Disease (PD)
        3. Huntington's Disease
        4. Stroke
        5. Traumatic Brain Injury (TBI)
        6. Amyotrophic Lateral Sclerosis (ALS)
        7. Muscle regeneration
        8. Others
    8. Spain Neurology Clinical Trials Market Size Analysis
      1. Introduction
      2. Neurology Clinical Trials Market Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      3. Neurology Clinical Trials Market Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
        1. Interventional
        2. Observational
        3. Expanded Access
      4. Neurology Clinical Trials Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Epilepsy
        2. Parkinson's Disease (PD)
        3. Huntington's Disease
        4. Stroke
        5. Traumatic Brain Injury (TBI)
        6. Amyotrophic Lateral Sclerosis (ALS)
        7. Muscle regeneration
        8. Others
    9. Italy Neurology Clinical Trials Market Size Analysis
      1. Introduction
      2. Neurology Clinical Trials Market Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      3. Neurology Clinical Trials Market Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
        1. Interventional
        2. Observational
        3. Expanded Access
      4. Neurology Clinical Trials Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Epilepsy
        2. Parkinson's Disease (PD)
        3. Huntington's Disease
        4. Stroke
        5. Traumatic Brain Injury (TBI)
        6. Amyotrophic Lateral Sclerosis (ALS)
        7. Muscle regeneration
        8. Others
    10. Russia Neurology Clinical Trials Market Size Analysis
      1. Introduction
      2. Neurology Clinical Trials Market Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      3. Neurology Clinical Trials Market Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
        1. Interventional
        2. Observational
        3. Expanded Access
      4. Neurology Clinical Trials Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Epilepsy
        2. Parkinson's Disease (PD)
        3. Huntington's Disease
        4. Stroke
        5. Traumatic Brain Injury (TBI)
        6. Amyotrophic Lateral Sclerosis (ALS)
        7. Muscle regeneration
        8. Others
    11. Nordic Neurology Clinical Trials Market Size Analysis
      1. Introduction
      2. Neurology Clinical Trials Market Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      3. Neurology Clinical Trials Market Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
        1. Interventional
        2. Observational
        3. Expanded Access
      4. Neurology Clinical Trials Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Epilepsy
        2. Parkinson's Disease (PD)
        3. Huntington's Disease
        4. Stroke
        5. Traumatic Brain Injury (TBI)
        6. Amyotrophic Lateral Sclerosis (ALS)
        7. Muscle regeneration
        8. Others
    12. Benelux Neurology Clinical Trials Market Size Analysis
      1. Introduction
      2. Neurology Clinical Trials Market Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      3. Neurology Clinical Trials Market Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
        1. Interventional
        2. Observational
        3. Expanded Access
      4. Neurology Clinical Trials Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Epilepsy
        2. Parkinson's Disease (PD)
        3. Huntington's Disease
        4. Stroke
        5. Traumatic Brain Injury (TBI)
        6. Amyotrophic Lateral Sclerosis (ALS)
        7. Muscle regeneration
        8. Others
    13. Rest of Europe Neurology Clinical Trials Market Size Analysis
      1. Introduction
      2. Neurology Clinical Trials Market Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      3. Neurology Clinical Trials Market Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
        1. Interventional
        2. Observational
        3. Expanded Access
      4. Neurology Clinical Trials Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Epilepsy
        2. Parkinson's Disease (PD)
        3. Huntington's Disease
        4. Stroke
        5. Traumatic Brain Injury (TBI)
        6. Amyotrophic Lateral Sclerosis (ALS)
        7. Muscle regeneration
        8. Others
  9. APAC Neurology Clinical Trials Market Size Analysis
    1. Introduction
    2. Neurology Clinical Trials Market Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
      1. Phase I
      2. Phase II
      3. Phase III
      4. Phase IV
    3. Neurology Clinical Trials Market Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
      1. Interventional
      2. Observational
      3. Expanded Access
    4. Neurology Clinical Trials Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
      1. Epilepsy
      2. Parkinson's Disease (PD)
      3. Huntington's Disease
      4. Stroke
      5. Traumatic Brain Injury (TBI)
      6. Amyotrophic Lateral Sclerosis (ALS)
      7. Muscle regeneration
      8. Others
    5. China Neurology Clinical Trials Market Size Analysis
      1. Introduction
      2. Neurology Clinical Trials Market Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      3. Neurology Clinical Trials Market Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
        1. Interventional
        2. Observational
        3. Expanded Access
      4. Neurology Clinical Trials Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Epilepsy
        2. Parkinson's Disease (PD)
        3. Huntington's Disease
        4. Stroke
        5. Traumatic Brain Injury (TBI)
        6. Amyotrophic Lateral Sclerosis (ALS)
        7. Muscle regeneration
        8. Others
    6. Korea Neurology Clinical Trials Market Size Analysis
      1. Introduction
      2. Neurology Clinical Trials Market Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      3. Neurology Clinical Trials Market Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
        1. Interventional
        2. Observational
        3. Expanded Access
      4. Neurology Clinical Trials Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Epilepsy
        2. Parkinson's Disease (PD)
        3. Huntington's Disease
        4. Stroke
        5. Traumatic Brain Injury (TBI)
        6. Amyotrophic Lateral Sclerosis (ALS)
        7. Muscle regeneration
        8. Others
    7. Japan Neurology Clinical Trials Market Size Analysis
      1. Introduction
      2. Neurology Clinical Trials Market Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      3. Neurology Clinical Trials Market Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
        1. Interventional
        2. Observational
        3. Expanded Access
      4. Neurology Clinical Trials Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Epilepsy
        2. Parkinson's Disease (PD)
        3. Huntington's Disease
        4. Stroke
        5. Traumatic Brain Injury (TBI)
        6. Amyotrophic Lateral Sclerosis (ALS)
        7. Muscle regeneration
        8. Others
    8. India Neurology Clinical Trials Market Size Analysis
      1. Introduction
      2. Neurology Clinical Trials Market Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      3. Neurology Clinical Trials Market Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
        1. Interventional
        2. Observational
        3. Expanded Access
      4. Neurology Clinical Trials Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Epilepsy
        2. Parkinson's Disease (PD)
        3. Huntington's Disease
        4. Stroke
        5. Traumatic Brain Injury (TBI)
        6. Amyotrophic Lateral Sclerosis (ALS)
        7. Muscle regeneration
        8. Others
    9. Australia Neurology Clinical Trials Market Size Analysis
      1. Introduction
      2. Neurology Clinical Trials Market Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      3. Neurology Clinical Trials Market Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
        1. Interventional
        2. Observational
        3. Expanded Access
      4. Neurology Clinical Trials Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Epilepsy
        2. Parkinson's Disease (PD)
        3. Huntington's Disease
        4. Stroke
        5. Traumatic Brain Injury (TBI)
        6. Amyotrophic Lateral Sclerosis (ALS)
        7. Muscle regeneration
        8. Others
    10. Taiwan Neurology Clinical Trials Market Size Analysis
      1. Introduction
      2. Neurology Clinical Trials Market Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      3. Neurology Clinical Trials Market Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
        1. Interventional
        2. Observational
        3. Expanded Access
      4. Neurology Clinical Trials Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Epilepsy
        2. Parkinson's Disease (PD)
        3. Huntington's Disease
        4. Stroke
        5. Traumatic Brain Injury (TBI)
        6. Amyotrophic Lateral Sclerosis (ALS)
        7. Muscle regeneration
        8. Others
    11. South East Asia Neurology Clinical Trials Market Size Analysis
      1. Introduction
      2. Neurology Clinical Trials Market Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      3. Neurology Clinical Trials Market Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
        1. Interventional
        2. Observational
        3. Expanded Access
      4. Neurology Clinical Trials Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Epilepsy
        2. Parkinson's Disease (PD)
        3. Huntington's Disease
        4. Stroke
        5. Traumatic Brain Injury (TBI)
        6. Amyotrophic Lateral Sclerosis (ALS)
        7. Muscle regeneration
        8. Others
    12. Rest of Asia-Pacific Neurology Clinical Trials Market Size Analysis
      1. Introduction
      2. Neurology Clinical Trials Market Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      3. Neurology Clinical Trials Market Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
        1. Interventional
        2. Observational
        3. Expanded Access
      4. Neurology Clinical Trials Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Epilepsy
        2. Parkinson's Disease (PD)
        3. Huntington's Disease
        4. Stroke
        5. Traumatic Brain Injury (TBI)
        6. Amyotrophic Lateral Sclerosis (ALS)
        7. Muscle regeneration
        8. Others
  10. Middle East and Africa Neurology Clinical Trials Market Size Analysis
    1. Introduction
    2. Neurology Clinical Trials Market Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
      1. Phase I
      2. Phase II
      3. Phase III
      4. Phase IV
    3. Neurology Clinical Trials Market Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
      1. Interventional
      2. Observational
      3. Expanded Access
    4. Neurology Clinical Trials Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
      1. Epilepsy
      2. Parkinson's Disease (PD)
      3. Huntington's Disease
      4. Stroke
      5. Traumatic Brain Injury (TBI)
      6. Amyotrophic Lateral Sclerosis (ALS)
      7. Muscle regeneration
      8. Others
    5. UAE Neurology Clinical Trials Market Size Analysis
      1. Introduction
      2. Neurology Clinical Trials Market Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      3. Neurology Clinical Trials Market Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
        1. Interventional
        2. Observational
        3. Expanded Access
      4. Neurology Clinical Trials Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Epilepsy
        2. Parkinson's Disease (PD)
        3. Huntington's Disease
        4. Stroke
        5. Traumatic Brain Injury (TBI)
        6. Amyotrophic Lateral Sclerosis (ALS)
        7. Muscle regeneration
        8. Others
    6. Turkey Neurology Clinical Trials Market Size Analysis
      1. Introduction
      2. Neurology Clinical Trials Market Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      3. Neurology Clinical Trials Market Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
        1. Interventional
        2. Observational
        3. Expanded Access
      4. Neurology Clinical Trials Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Epilepsy
        2. Parkinson's Disease (PD)
        3. Huntington's Disease
        4. Stroke
        5. Traumatic Brain Injury (TBI)
        6. Amyotrophic Lateral Sclerosis (ALS)
        7. Muscle regeneration
        8. Others
    7. Saudi Arabia Neurology Clinical Trials Market Size Analysis
      1. Introduction
      2. Neurology Clinical Trials Market Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      3. Neurology Clinical Trials Market Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
        1. Interventional
        2. Observational
        3. Expanded Access
      4. Neurology Clinical Trials Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Epilepsy
        2. Parkinson's Disease (PD)
        3. Huntington's Disease
        4. Stroke
        5. Traumatic Brain Injury (TBI)
        6. Amyotrophic Lateral Sclerosis (ALS)
        7. Muscle regeneration
        8. Others
    8. South Africa Neurology Clinical Trials Market Size Analysis
      1. Introduction
      2. Neurology Clinical Trials Market Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      3. Neurology Clinical Trials Market Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
        1. Interventional
        2. Observational
        3. Expanded Access
      4. Neurology Clinical Trials Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Epilepsy
        2. Parkinson's Disease (PD)
        3. Huntington's Disease
        4. Stroke
        5. Traumatic Brain Injury (TBI)
        6. Amyotrophic Lateral Sclerosis (ALS)
        7. Muscle regeneration
        8. Others
    9. Egypt Neurology Clinical Trials Market Size Analysis
      1. Introduction
      2. Neurology Clinical Trials Market Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      3. Neurology Clinical Trials Market Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
        1. Interventional
        2. Observational
        3. Expanded Access
      4. Neurology Clinical Trials Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Epilepsy
        2. Parkinson's Disease (PD)
        3. Huntington's Disease
        4. Stroke
        5. Traumatic Brain Injury (TBI)
        6. Amyotrophic Lateral Sclerosis (ALS)
        7. Muscle regeneration
        8. Others
    10. Nigeria Neurology Clinical Trials Market Size Analysis
      1. Introduction
      2. Neurology Clinical Trials Market Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      3. Neurology Clinical Trials Market Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
        1. Interventional
        2. Observational
        3. Expanded Access
      4. Neurology Clinical Trials Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Epilepsy
        2. Parkinson's Disease (PD)
        3. Huntington's Disease
        4. Stroke
        5. Traumatic Brain Injury (TBI)
        6. Amyotrophic Lateral Sclerosis (ALS)
        7. Muscle regeneration
        8. Others
    11. Rest of MEA Neurology Clinical Trials Market Size Analysis
      1. Introduction
      2. Neurology Clinical Trials Market Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      3. Neurology Clinical Trials Market Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
        1. Interventional
        2. Observational
        3. Expanded Access
      4. Neurology Clinical Trials Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Epilepsy
        2. Parkinson's Disease (PD)
        3. Huntington's Disease
        4. Stroke
        5. Traumatic Brain Injury (TBI)
        6. Amyotrophic Lateral Sclerosis (ALS)
        7. Muscle regeneration
        8. Others
  11. LATAM Neurology Clinical Trials Market Size Analysis
    1. Introduction
    2. Neurology Clinical Trials Market Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
      1. Phase I
      2. Phase II
      3. Phase III
      4. Phase IV
    3. Neurology Clinical Trials Market Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
      1. Interventional
      2. Observational
      3. Expanded Access
    4. Neurology Clinical Trials Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
      1. Epilepsy
      2. Parkinson's Disease (PD)
      3. Huntington's Disease
      4. Stroke
      5. Traumatic Brain Injury (TBI)
      6. Amyotrophic Lateral Sclerosis (ALS)
      7. Muscle regeneration
      8. Others
    5. Brazil Neurology Clinical Trials Market Size Analysis
      1. Introduction
      2. Neurology Clinical Trials Market Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      3. Neurology Clinical Trials Market Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
        1. Interventional
        2. Observational
        3. Expanded Access
      4. Neurology Clinical Trials Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Epilepsy
        2. Parkinson's Disease (PD)
        3. Huntington's Disease
        4. Stroke
        5. Traumatic Brain Injury (TBI)
        6. Amyotrophic Lateral Sclerosis (ALS)
        7. Muscle regeneration
        8. Others
    6. Mexico Neurology Clinical Trials Market Size Analysis
      1. Introduction
      2. Neurology Clinical Trials Market Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      3. Neurology Clinical Trials Market Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
        1. Interventional
        2. Observational
        3. Expanded Access
      4. Neurology Clinical Trials Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Epilepsy
        2. Parkinson's Disease (PD)
        3. Huntington's Disease
        4. Stroke
        5. Traumatic Brain Injury (TBI)
        6. Amyotrophic Lateral Sclerosis (ALS)
        7. Muscle regeneration
        8. Others
    7. Argentina Neurology Clinical Trials Market Size Analysis
      1. Introduction
      2. Neurology Clinical Trials Market Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      3. Neurology Clinical Trials Market Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
        1. Interventional
        2. Observational
        3. Expanded Access
      4. Neurology Clinical Trials Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Epilepsy
        2. Parkinson's Disease (PD)
        3. Huntington's Disease
        4. Stroke
        5. Traumatic Brain Injury (TBI)
        6. Amyotrophic Lateral Sclerosis (ALS)
        7. Muscle regeneration
        8. Others
    8. Chile Neurology Clinical Trials Market Size Analysis
      1. Introduction
      2. Neurology Clinical Trials Market Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      3. Neurology Clinical Trials Market Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
        1. Interventional
        2. Observational
        3. Expanded Access
      4. Neurology Clinical Trials Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Epilepsy
        2. Parkinson's Disease (PD)
        3. Huntington's Disease
        4. Stroke
        5. Traumatic Brain Injury (TBI)
        6. Amyotrophic Lateral Sclerosis (ALS)
        7. Muscle regeneration
        8. Others
    9. Colombia Neurology Clinical Trials Market Size Analysis
      1. Introduction
      2. Neurology Clinical Trials Market Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      3. Neurology Clinical Trials Market Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
        1. Interventional
        2. Observational
        3. Expanded Access
      4. Neurology Clinical Trials Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Epilepsy
        2. Parkinson's Disease (PD)
        3. Huntington's Disease
        4. Stroke
        5. Traumatic Brain Injury (TBI)
        6. Amyotrophic Lateral Sclerosis (ALS)
        7. Muscle regeneration
        8. Others
    10. Rest of LATAM Neurology Clinical Trials Market Size Analysis
      1. Introduction
      2. Neurology Clinical Trials Market Market Size & Forecast By Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      3. Neurology Clinical Trials Market Market Size & Forecast By Study Design 2022-2034 (USD MILLION/ Units)
        1. Interventional
        2. Observational
        3. Expanded Access
      4. Neurology Clinical Trials Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Epilepsy
        2. Parkinson's Disease (PD)
        3. Huntington's Disease
        4. Stroke
        5. Traumatic Brain Injury (TBI)
        6. Amyotrophic Lateral Sclerosis (ALS)
        7. Muscle regeneration
        8. Others
  12. Competitive Landscape
    1. Neurology Clinical Trials Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. IQVIA
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Novartis
    3. Covance
    4. Medpace
    5. Charles River Laboratories
    6. SyneousHealth
    7. Icon Plc
    8. GlaxoSmithKline
    9. Aurora healthcare
    10. Biogen
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports

  16. Disclaimer
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on: